Published in:
01-12-2017
Inadequate glycaemic control and therapeutic management of adults over 65 years old with type 2 diabetes mellitus in Spain
Published in: The journal of nutrition, health & aging | Issue 10/2017
Login to get accessAbstract
Objectives
The glycaemic goals for older patients with type 2 diabetes mellitus (DM) are recommended to avoid an HbA1c levels <7%. The purpose of this study was to analyse the glycaemic control and therapeutic management of older adults (≥65 years) with type 2 DM.
Design
Pooled analysis of patients enrolled in three Spanish cross-sectional epidemiological studies.
Setting
The study was conducted between 2009 and 2011 by primary care or specialist physicians.
Participants
A total of 7,269 patients aged ≥65 years with type 2 DM.
Measurements
Sociodemographic, medical history, lifestyle habits, biochemical laboratory parameters, comorbidities, type 2 DM complications, and pharmacological treatment data collected from medical records.
Results
In total, data from 7,269 patients were analysed (mean age 73.4 years old; 48.4% male). A total of 10.9% of patients had HbA1c levels ≥8.5% and 43.2% <7%. The most common comorbidities were hypertension (82.0%) and dyslipidaemia (76.6%). The microvascular complications were mainly diabetic nephropathy (23.6%) and retinopathy (19.3%). Oral antidiabetic drugs (OADs) were taken by 70.5% of patients (sulphonylureas 65.3%), 4.1% were taking insulin alone and 25.4% took both insulin and an OAD. Half of the patients (51.0%) were taking a combination of OADs.
Conclusion
In conclusion, more than half of older patients with type 2 DM had unsatisfactory management: approximately one in ten had inadequate glycaemic control (HbA1c ≥8.5%) despite hypoglycaemic drugs and four in ten were potentially overtreated (HbA1c <7%).